Talking Euretina

A diagnosis of uveal melanoma during pregnancy forces an agonising question: treat now, or wait? Dr Emine Kiliç chairs a multidisciplinary discussion with Dr Iwona Rospond-Kubiak (Poznań), Prof. Antonia Joussen (Charité, Berlin) and radiation oncologist Dr Adam Chicheł on plaque brachytherapy and fetal radiation exposure, how gestational age shapes timing, and the reassuring — if limited — evidenc...

Euretina will shortly relaunch the Women in Retina survey, building on the first dataset. In this podcast, Prof. Anat Loewenstein, Dr Federica Fossataro and Prof. Nicole Eter explore what has changed since the original 2021 study, what's new and why participation from the whole community - women and men alike - is essential to measuring real progress. The Women In Retina Initiative is sponsored by...

New therapies are reshaping geographic atrophy—but are trial endpoints keeping pace with clinical reality? Anat Loewenstein is joined by Sobha Sivaprasad and Kristina Pfau to examine how success in GA is measured, from lesion growth to functional vision. The panel explores microperimetry, contrast sensitivity, and emerging tools that may better reflect meaningful patient outcomes.

A landmark Phase 3 trial has delivered the first positive result for Stargardt disease treatment — but the therapeutic landscape is shifting fast. Prof. Maximilian Pfau enjoys a discussion with Prof. Carel Hoyng and Dr. Karolina Kaminska on the ABCA4 disease spectrum, the groundbreaking discovery of AP5 complex-related macular dystrophy, and emerging therapies from oral drugs to gene-specific appr...

Three former mentees of the EURETINA Mentorship Programme share how the initiative helped shape their careers in retinal research and clinical practice. Özge Yanık Odabaş, Karolina Motloch and Omer Trivizki discuss mentorship, international collaboration, and the opportunities created through the programme’s growing alumni network. Their experiences highlight how structured mentorship can accelera...

Artificial intelligence is rapidly reshaping retina care — but where does it truly add value in daily practice? Professors Tien Wong and Daniel Ting join Stela Vujosevic to explore how AI is moving beyond screening into risk stratification, clinical decision support, and home monitoring. From infrastructure challenges to real-world implementation, this episode offers practical insights for retina...

Artificial intelligence is rapidly reshaping how we screen, classify, and treat diabetic retinal disease. Professor Aude Couturier, Professor Edoardo Midena, and Professor Reinier Schlingemann discuss real-world AI applications in diabetic retinopathy — from population screening and imaging biomarkers to phenotyping and precision treatment in diabetic macular oedema

What drives leading retina specialists to trade the clinic for corporate innovation? In this episode, Euretina Board member Kourous Rezaei speaks with Jay Duker (CEO, Eyepoint), Sascha Fauser (SVP, Roche), and Marion Munk (CSO, Gutblick Group; CMO, Isarna Therapeutics) about their transitions from clinical practice to industry. Together they share insights on leadership, research, and the evolving...

In this episode Professors Dean Eliott, Grazia Pertile, and José García-Arumí join chair Kourous Rezaei to explore how surgical mastery is built through intuition, preparation, and reflection. They share practical insights on mentorship, focus, teamwork, and managing stressful cases — from avoiding coffee before surgery to resetting after complications — revealing that great surgeons are defined n...

In this first-ever debate edition of Talking Euretina, Dr Rumana Hussain (Liverpool Ocular Oncology Centre) introduces Professors Arun Singh (Cole Eye Institute, Cleveland Clinic), Heinrich Heimann (Liverpool Ocular Oncology Service) and Bertil Damato (Moorfields Eye Hospital) as they debate one of ocular oncology’s most enduring questions — when to operate on small choroidal melanomas. The panel...

Retinal diseases disproportionately affect certain populations—yet these groups are underrepresented in research. In this episode, Dr. Christiana Dinah chairs a global panel including Drs. Adrienne Scott, Charles Wykoff and Jeremiah Brown to explore the systemic and structural barriers to inclusion in retina trials, and why the stakes for equity have never been higher

In this episode, Prof. Frank Holz leads a panel discussion on a major leap forward in retinal prosthesis: the Prima system for geographic atrophy. Joined by Dr. Mahi Muqit and Prof. Lars-Olof Hattenbach, they explore how their extraordinary wireless subretinal implant is restoring visual perception in late-stage AMD. 

In this episode, Profs. Lejla Vajzovic (USA), Sandrine Zweifel (Switzerland), and Heinrich Heimann (UK) reflect on a fantastic few days in Paris and share their highlights from the 2025 programme for you to watch back through the portal.

Euretina President Prof. Anat Loewenstein speaks with Prof. Ursula Schmidt-Erfurth, 25th Euretina Lecturer, about her groundbreaking career in retinal disease, from imaging innovations to AI-driven early detection. They discuss the EU-funded iScreen project, the future of AMD management, and the significance of two women presidents (past and present) as Euretina celebrates its 25th anniversary in...

Ahead of his Gisbert Richard Lecture at this year’s Euretina Congress in Paris, Prof. Jean-François Korobelnik joins Prof. Nicole Eter to reflect on a career at the forefront of retinal research. From surgical breakthroughs to his leadership of the E3 consortium, and his cautious optimism for AI, Prof. Korobelnik shares insights on past progress and future priorities in retina

Ahead of her Kreissig Award Lecture at the Euretina Congress in Paris, Professor Maria Berrocal (Puerto Rico) joins Euretina past president Alistair Laidlaw to discuss why time-tested treatments like PRP and scleral buckling still matter. They explore the risks of over-reliance on anti-VEGF in proliferative diabetic retinopathy, the decline in buckle training, and how chandelier techniques could r...

In this thought-provoking episode, Professor Tariq Aslam and Retina International’s Avril Daly join Jonathan McCrea to explore the emotional and psychological dimensions of retinal disease. From the power of empathy in clinical care to the need for integrated mental health services, the discussion highlights why supporting patients beyond the medical chart is more vital than ever—especially in an...

Ahead of her Ophthalmologica Lecture at this year’s Euretina Congress, Dr. Maria Vittoria Cicinelli joins Professor Bahram Bodaghi to explore the evolving understanding of white spot syndromes. From classic presentations of punctate inner choroidopathy (PIC) to emerging imaging insights and therapeutic uncertainties, the conversation highlights unmet needs, research gaps, and practical implication...

In this episode, Prof. Martin Zinkernagel and Dr. Matias Iglicki spotlight Ophthalmologica’s new article collection on submacular hemorrhages. They explore key findings from four studies covering imaging, surgical strategies, and real-world outcomes, offering timely insights into managing this vision-threatening condition.

Ever considered broadening your professional horizons with an ophthalmology fellowship abroad? In this insightful episode, Dr. Peter Kiraly (Manchester Royal Eye Hospital) and Dr. Elon van Dijk (Leiden University Medical Center and Rotterdam Eye Hospital) share their personal journeys and practical advice from fellowships in the UK and Australia. Chaired by Jonathan McCrea

When should you refer and what should you include? Oncologists Hibba Quhill, Iwona Rospond-Kubiak, and Emine Kilic share practical, experience-based advice on improving referral pathways in ocular oncology. From triage strategies to imaging essentials, this episode covers what referring clinicians need to know to ensure timely and effective patient care

Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.

Prof. Zohar Habot-Wilner (Tel Aviv University) chairs a rich discussion with Prof. Sofia Androudi (University of Thessaly, Greece) and Prof. Sarah Touhami (University of Sorbonne) on managing retinal and uveitic diseases during pregnancy. They explore safe diagnostic tools, therapeutic dilemmas like Ranibizumab vs. Ozurdex, and the effects of pregnancy-related hormonal shifts—highlighting the impo...

What are hyperreflective foci, and why do they matter in AMD? Prof. Stella Vujosevic is joined by Prof. Christine Curcio (University of Alabama at Birmingham) and Prof. Srinivas Sadda (Doheny Eye Institute, UCLA) to explore their significance—from donor eye histology to OCT imaging. They discuss key biomarkers, clinical implications, and how HRF can help guide treatment decisions in age-related ma...

What causes central serous chorioretinopathy (CSC), and how should it be managed? In this episode, experts Camiel Boon, Sobha Sivaprasad, and Gemmy Cheung discuss the latest insights into CSC and the pachychoroid spectrum, including new imaging findings, risk factors, and treatment options like PDT, laser, and anti-VEGF